BioAdaptives Inc. (BDPT)

0.00 +0.00% (+0.00)

Over 5Y: -100.0%

2026-08-28
2 4
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 5.3K Q3 '21 — Operating Cash Flow: -33.2K Q3 '21 — Net Income: -34.5K Q4 '21 — Revenue: 3.9K Q4 '21 — Operating Cash Flow: -35.4K Q4 '21 — Net Income: -214.3K Q1 '22 — Revenue: 5.5K Q1 '22 — Operating Cash Flow: -61.2K Q1 '22 — Net Income: -367.1K Q2 '22 — Revenue: 4.3K Q2 '22 — Operating Cash Flow: -77.1K Q2 '22 — Net Income: -223.8K Q3 '22 — Revenue: 3.3K Q3 '22 — Operating Cash Flow: -61.5K Q3 '22 — Net Income: -276.3K Q4 '22 — Revenue: 4K Q4 '22 — Operating Cash Flow: -27.5K Q4 '22 — Net Income: -28.3K Q1 '23 — Revenue: 3.4K Q1 '23 — Operating Cash Flow: -19.5K Q1 '23 — Net Income: -287.2K Q2 '23 — Revenue: 2.3K Q2 '23 — Operating Cash Flow: -56.9K Q2 '23 — Net Income: -143.9K Q3 '23 — Revenue: 15.6K Q3 '23 — Operating Cash Flow: -56.1K Q3 '23 — Net Income: -13.1K Q4 '23 — Revenue: 7.2K Q4 '23 — Operating Cash Flow: -91.3K Q4 '23 — Net Income: -268.3K Q1 '24 — Revenue: 12K Q1 '24 — Operating Cash Flow: -41.2K Q1 '24 — Net Income: -306.7K Q2 '24 — Revenue: 675 Q2 '24 — Operating Cash Flow: -51.5K Q2 '24 — Net Income: -183K Q3 '24 — Revenue: 0 Q3 '24 — Operating Cash Flow: -56.3K Q3 '24 — Free Cash Flow: -56.3K Q3 '24 — Net Income: -37.6K Q4 '24 — Revenue: 0 Q4 '24 — Operating Cash Flow: -100.5K Q4 '24 — Free Cash Flow: -100.5K Q4 '24 — Net Income: -371.8K Q1 '25 — Revenue: 0 Q1 '25 — Operating Cash Flow: -97.9K Q1 '25 — Net Income: -197.1K Q2 '25 — Revenue: 3.2K Q2 '25 — Operating Cash Flow: -111K Q2 '25 — Net Income: -157.9K Q3 '25 — Revenue: 4.6K Q3 '25 — Operating Cash Flow: -151.3K Q3 '25 — Free Cash Flow: -151.3K Q3 '25 — Net Income: -379.5K Q4 '25 — Revenue: 10.4K Q4 '25 — Operating Cash Flow: -155.8K Q4 '25 — Free Cash Flow: -155.8K Q4 '25 — Net Income: -823.3K Q1 '26 — Revenue: 5.5K Q1 '26 — Operating Cash Flow: -84.8K Q1 '26 — Net Income: -111.1K Q2 '26 — Revenue: 5K Q2 '26 — Operating Cash Flow: -44.4K Q2 '26 — Net Income: 150.1K -800K -600K -400K -200K 0 200K
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

1.0
SBC / sales 112.2%
Accruals -923.6%
Gross margin 77.4%
FCF margin -1777.6%
OCF margin -1707.1%
ROA -1477.6%
EBITDA margin —
OCF / EBIT —
OE margin —
Oper. margin —
Profit margin —
ROCE —
ROE —
ROIC —

1 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.037×
Interest cover -17.4×
Cash / Debt 0.06×
F-score 3.4 pts
Quick ratio 0.017×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.2
Sales/sh Y/Y +547.6%
Sales Q/Q +55.0%
Shares change +22.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.